{
    "patient": {
        "Name": "Samantha Foster",
        "DateOfBirth": "1934-04-13",
        "Sex": "Male",
        "Diagnosis": "Merkel cell carcinoma",
        "BodyPart": "Skin",
        "Physician": "Dr. Jared Brooks",
        "TreatingInstitution": "Morgan-Carrillo"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Skin",
            "CollectedDate": "2023-10-26",
            "ReceivedDate": "2023-10-26",
            "TumorPercentage": "70%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2023-10-30",
            "ReceivedDate": "2023-11-01"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "NRAS",
                "DNA Alteration": "c.181C>G",
                "GeneMutation": "p.Q61X Nonsense-GOF",
                "VariantAlleleFraction": "7.27%"
            },
            {
                "Gene": "HDAC1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.Y303H Frameshift-GOF",
                "VariantAlleleFraction": "32.68%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "FGFR2",
                "DNA Alteration": "c.1124A>G",
                "GeneMutation": "p.C382R Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "14.51%"
            },
            {
                "Gene": "BRCA1",
                "DNA Alteration": "c.5265_5266insC",
                "GeneMutation": "p.S372C Frameshift-GOF",
                "VariantAlleleFraction": "17.58%"
            },
            {
                "Gene": "STAG2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.V679F Spliceregionvariant-GOF",
                "VariantAlleleFraction": "5.5%"
            },
            {
                "Gene": "MYD88",
                "DNA Alteration": "c.794T>C",
                "GeneMutation": "p.Y375C Nonsense-GOF",
                "VariantAlleleFraction": "9.14%"
            },
            {
                "Gene": "CALR",
                "DNA Alteration": "c.1092_1143del52",
                "GeneMutation": "p.L367fs*46 Spliceregionvariant-GOF",
                "VariantAlleleFraction": "5.27%"
            },
            {
                "Gene": "FLT3",
                "DNA Alteration": "c.2525A>G",
                "GeneMutation": "p.Y375C Spliceregionvariant-GOF",
                "VariantAlleleFraction": "2.1%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "CSF3R"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "31 m/Mb",
            "Tmbpercentile": "1%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "Stable"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}